Genetic association of lipids and lipid-lowering drug target genes with Endometrial carcinoma: a drug target Mendelian randomization study

BackgroundAberrant lipid metabolism is intricately linked to the development of endometrial cancer, and statin lipid-lowering medications are regarded as promising adjunctive therapies for future management of this malignancy. This study employed Mendelian randomization (MR) to explore the causal as...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zhehan Yang, Junpan Chen, Minghao Wen, Jiayuan Lei, Ming Zeng, Sichen Li, Yao Long, Zhiyi Zhou, Chunyan Wang
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2024-08-01
Schriftenreihe:	Frontiers in Endocrinology
Schlagworte:	endometrioid carcinoma mendelian randomization APOB CETP drug target
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1446457/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!